"We have taken biopharmaceuticals from early concept studies all the way to market approval."

Dr Roger Lias

President, Eden Biodesign, Inc. & Group Commercial Director

roger.lias@edenbiodesign.com

Roger is responsible for worldwide biologics business development and his responsibilities include identifying and establishing strong strategic business partnerships and alliances in support of Watson Pharmaceuticals’ move towards a leadership position in the global biologics market.

Roger has extensive experience in the biotechnology industry with a specific emphasis on biomanufacturing. Prior to joining Eden, Roger held the position of Vice President, Sales and Business Development at Cytovance Biologics and KBI BioPharma, where he played an active role in securing funding, building revenues and the identification and establishment of strategic business partnerships and relationships. Prior to this, he was Vice President, Business Development at Diosynth where he had global responsibility and headed North American sales and marketing for Lonza Biologics. In both cases Roger was instrumental in generating substantial revenue growth.